Skip to main content

Table 2 Comparison of UCP-2 gene variants between all MM patients and the healthy control group

From: Effect of the uncoupling protein-2 (UCP-2) and nuclear receptor subfamily 3 group C member 1 (NR3C1) genes on treatment efficacy and survival in patients with multiple myeloma: a single-center study

 

Genotype

MM

Healthy Controls

OR

Exp(B)

95% CI

p&

 

n (%)

n (%)

   

UCP-2

AA

92 (46)

32 (16)

0.813

0.116–0.411

0.001*

 

AG

86 (43)

125 (62.5)

0.944

0.413–1.322

0.093

 

GG

22 (11)

43 (21.5)

0.855

0.164–0.889

0.036*

Allele

      
 

A

270 (67.5)

189 (47.25)

   
 

G

130 (32.5)

211 (52.75)

0.667

0.355–0.699

0.001*

  1. MM Multiple myeloma, ASCT autologous stem cell transplantation, *statistical significance